Medical Genetics

Date : December 12, 1994 H.T. Orr, M. Chung, S. Banfi, T.J. Kwiatkowski, Jr., A. Servadio, A.L. Beaudet, A.E. McCall, L.A. Duvick, L.P.W. Ranum, H.Y. Zoghbi, "Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1," Nature Genetics, 4:221-26, 1993. (Cited in 114 publications through October 1994) The subject of this paper, the genetic basis of the neurodegenerative disease spinocerebellar ataxia type 1

Written byNeeraja Sankaran
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Date : December 12, 1994

H.T. Orr, M. Chung, S. Banfi, T.J. Kwiatkowski, Jr., A. Servadio, A.L. Beaudet, A.E. McCall, L.A. Duvick, L.P.W. Ranum, H.Y. Zoghbi, "Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1," Nature Genetics, 4:221-26, 1993. (Cited in 114 publications through October 1994)

The subject of this paper, the genetic basis of the neurodegenerative disease spinocerebellar ataxia type 1 (SCA1), has been the focus of an ongoing collaboration between the laboratories of Harry Orr at the University of Minnesota, Minneapolis, and Huda Zoghbi at Baylor College of Medicine in Houston.

"It demonstrates that the DNA mutation that causes SCA1 is the expansion of an unstable trinucleotide--CAG, in this case--repeat in the coding region of the gene for a protein called ataxin 1," explains Orr, who is a professor of laboratory medicine and pathology and a member of the Institute of Human Genetics at Minnesota.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies